{"id":262105,"date":"2026-09-22T14:21:43","date_gmt":"2026-09-22T08:51:43","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=262105"},"modified":"2026-09-22T14:21:43","modified_gmt":"2026-09-22T08:51:43","slug":"why-mankind-pharma-ltd-share-price-price-rise-2026-09-22","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/","title":{"rendered":"Mankind Pharma Ltd. (MANKIND): Mankind Pharma Share Price Rises 2.19% Today to Rs 2,483"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/mankind\/mankind-pharma-ltd-share-price-today\">Mankind Pharma Ltd. (MANKIND)<\/a> share price rose to Rs 2,483 today, up 2.19% from the previous close. Market cap was Rs 95,743.85 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 22 September 2026 at 2:18:59 PM IST<\/p>\n<p style=\"margin-top:0!important;\">Mankind Pharma Share Price rose today to Rs 2,483, up 2.19% from the previous close of Rs 2,429.85, with the company\u2019s market capitalisation at Rs 95,743.85 crore. The day\u2019s move placed Mankind Pharma Ltd. among the Stocks in News in the Indian Stock Market, even though the supplied data does not establish a company-specific catalyst. The stock opened at Rs 2,445.60, touched a day high of Rs 2,486.70 and a day low of Rs 2,438, while turnover stood at Rs 23.14 crore. This Mankind Pharma Share Price update matters because it combines a clear same-day price rise with a sizeable listed-company footprint and a valuation profile that can be read against healthcare peers. For readers tracking Mankind Pharma Share Price Today, the next focus is on whether the move is sustained through subsequent sessions and how the market continues to assess the stock\u2019s fundamentals, sector context and peer comparison in Univest stock coverage.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#Mankind_Pharma_Share_Price_Today_Price_Action_Analysis\" title=\"Mankind Pharma Share Price Today: Price Action Analysis\">Mankind Pharma Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#Mankind_Pharma_Ltd_MANKIND_Fundamental_Analysis\" title=\"Mankind Pharma Ltd. (MANKIND) Fundamental Analysis\">Mankind Pharma Ltd. (MANKIND) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#Why_Investors_Are_Watching_Mankind_Pharma\" title=\"Why Investors Are Watching Mankind Pharma\">Why Investors Are Watching Mankind Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#About_Mankind_Pharma\" title=\"About Mankind Pharma\">About Mankind Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#Track_Mankind_Pharma_Share_Price_on_Univest\" title=\"Track Mankind Pharma Share Price on Univest\">Track Mankind Pharma Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#Why_is_Mankind_Pharma_Share_Price_rising_today\" title=\"Why is Mankind Pharma Share Price rising today?\">Why is Mankind Pharma Share Price rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#What_is_Mankind_Pharma_Share_Price_Today\" title=\"What is Mankind Pharma Share Price Today?\">What is Mankind Pharma Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#What_is_Mankind_Pharma_market_capitalisation\" title=\"What is Mankind Pharma market capitalisation?\">What is Mankind Pharma market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#What_does_Mankind_Pharma_Share_Price_indicate_on_valuation\" title=\"What does Mankind Pharma Share Price indicate on valuation?\">What does Mankind Pharma Share Price indicate on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#How_does_Mankind_Pharma_compare_with_healthcare_peers\" title=\"How does Mankind Pharma compare with healthcare peers?\">How does Mankind Pharma compare with healthcare peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#What_is_Mankind_Pharma_Share_Price_fundamental_analysis_telling_investors\" title=\"What is Mankind Pharma Share Price fundamental analysis telling investors?\">What is Mankind Pharma Share Price fundamental analysis telling investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#Is_Mankind_Pharma_part_of_the_Healthcare_sector\" title=\"Is Mankind Pharma part of the Healthcare sector?\">Is Mankind Pharma part of the Healthcare sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-22\/#Where_can_I_track_Mankind_Pharma_Share_Price_on_Univest\" title=\"Where can I track Mankind Pharma Share Price on Univest?\">Where can I track Mankind Pharma Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Mankind_Pharma_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Mankind Pharma Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,483<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,429.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 53.15 (+2.19%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,445.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,486.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,438<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 23.14 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 95,743.85 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/table>\n<p>Mankind Pharma Ltd. (MANKIND) rose to Rs 2,483 from the previous close of Rs 2,429.85, a move of Rs 53.15 or 2.19%. The stock opened at Rs 2,445.6, reached a high of Rs 2,486.7, recorded a low of Rs 2,438.<\/p>\n<p>Mankind Pharma Share Price Today showed a clean upward move, with the stock closing at Rs 2,483 after adding Rs 53.15, or 2.19%, over the previous close. The session range stretched from Rs 2,438 to Rs 2,486.70, which kept the stock close to its intraday peak. The opening price of Rs 2,445.60 also stayed above the previous close, showing that the session started with a firm gap-up versus the last close and then held most of the day\u2019s gains. Turnover of Rs 23.14 crore provides a factual snapshot of traded value for the day. In Mankind Pharma Stock News terms, today\u2019s move is best described as a share price gain supported by a high-of-day finish rather than by any verified company event in the supplied data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mankind_Pharma_Ltd_MANKIND_Fundamental_Analysis\"><\/span><strong>Mankind Pharma Ltd. (MANKIND) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 95,743.85 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 49.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 407.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.04%<\/td>\n<\/tr>\n<\/table>\n<p>Mankind Pharma Ltd. (MANKIND) fundamental metrics show P\/E 49.13x, P\/B 5.96x, ROE 12.69%, ROCE 13.24%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Mankind Pharma Ltd. has a market capitalisation of Rs 95743.85 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 49.13x, P\/B at 5.96x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.69% and ROCE of 13.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 49.45, book value per share of Rs 407.39, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.62x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.62x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.51x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.37x to 747.32x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.74%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 95,743.85 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 746.45 crore<\/td>\n<\/tr>\n<\/table>\n<p>Mankind Pharma Ltd. (MANKIND) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Mankind Pharma Ltd. (MANKIND) has a P\/E ratio of 49.13x, which is above the benchmark median of 32.62x, a difference of +50.61%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Mankind Pharma Ltd. (MANKIND) has a ROE of 12.69%, which is above the benchmark median of 11.74%, a difference of +8.09%. Mankind Pharma Ltd. (MANKIND) has a ROCE of 13.24%, which is below the benchmark median of 13.63%, a difference of -2.86%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,40,397.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.05<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,48,664.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">85.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,82,738.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.05<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,15,012.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,10,793.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Mankind Pharma Ltd. (MANKIND) has a P\/E ratio of 49.13x compared with the displayed peer median of 37.05x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 13.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Mankind Pharma Ltd. (MANKIND) has a market capitalisation of Rs 95,743.85 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Mankind_Pharma\"><\/span><strong>Why Investors Are Watching Mankind Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Mankind Pharma Share Price rose 2.19% today to Rs 2,483, after closing above the previous close of Rs 2,429.85.<\/li>\n<li>The day\u2019s high was Rs 2,486.70, which kept Mankind Pharma Share Price close to the session peak.<\/li>\n<li>Market capitalisation stood at Rs 95,743.85 crore, giving Mankind Pharma Stock News a large listed-company context.<\/li>\n<li>P\/E was 49.13, P\/B was 5.96, ROE was 12.69 and ROCE was 13.24 in the latest supplied data.<\/li>\n<li>In the same-industry benchmark, Mankind Pharma Share Price sits above the median on ROE and above the median on P\/B.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Mankind_Pharma\"><\/span><strong>About Mankind Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Mankind Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The business context supplied for Mankind Pharma Share Price is that of a large listed pharmaceutical company whose valuation and earnings profile can be compared with other Indian drug makers. Its market capitalisation of Rs 95,743.85 crore places it among the more valuable names in the industry benchmark supplied here. The available data highlights a revenue-generating listed company with EPS of Rs 49.45, book value of Rs 407.39 and dividend yield of 0.04, all of which help explain how the market is framing the stock. For readers tracking Mankind Pharma Company News, the key point is that the company should be assessed through its operating profile, valuation multiples and position in the pharmaceutical peer set. Univest presents this Mankind Pharma Stock News page as a factual market update for investors following the stock\u2019s daily movement.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Mankind_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Mankind Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/mankind\/mankind-pharma-ltd-share-price-today\">Mankind Pharma Ltd. (MANKIND) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Investors can track Mankind Pharma Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers monitor Mankind Pharma Share Price Today alongside sector context, peer comparison and company-level financial data in one place. For users following Mankind Pharma Stock News, this makes it easier to review price movement, valuation and company background together.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Mankind_Pharma_Share_Price_rising_today\"><\/span><strong>Why is Mankind Pharma Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mankind Pharma Share Price rose 2.19% to Rs 2,483 today, but the supplied data does not establish a company-specific catalyst. The move is confirmed by the day\u2019s open, high, low and previous close.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Mankind_Pharma_Share_Price_Today\"><\/span><strong>What is Mankind Pharma Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mankind Pharma Share Price Today is Rs 2,483. The stock gained Rs 53.15 from the previous close of Rs 2,429.85, and the session high reached Rs 2,486.70. The previous close was Rs 2,429.85.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Mankind_Pharma_market_capitalisation\"><\/span><strong>What is Mankind Pharma market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mankind Pharma\u2019s market capitalisation is Rs 95,743.85 crore. That places the company far above the same-industry benchmark median of Rs 746.45 crore and above the benchmark average of Rs 14,202.67 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Mankind_Pharma_Share_Price_indicate_on_valuation\"><\/span><strong>What does Mankind Pharma Share Price indicate on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mankind Pharma Share Price reflects a P\/E of 49.13 and a P\/B of 5.96. EPS is Rs 49.45 and book value is Rs 407.39, which helps frame the valuation context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Mankind_Pharma_compare_with_healthcare_peers\"><\/span><strong>How does Mankind Pharma compare with healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In the supplied peer set, Mankind Pharma sits above Zydus Lifesciences and Cipla on P\/E, but below Divi\u2019s Laboratories and Torrent Pharmaceuticals. Its market cap is also below Sun Pharmaceutical Industries Ltd.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Mankind_Pharma_Share_Price_fundamental_analysis_telling_investors\"><\/span><strong>What is Mankind Pharma Share Price fundamental analysis telling investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mankind Pharma Fundamental Analysis shows ROE of 12.69, ROCE of 13.24 and dividend yield of 0.04. The figures provide profitability and valuation context, but they do not by themselves explain today\u2019s move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Mankind_Pharma_part_of_the_Healthcare_sector\"><\/span><strong>Is Mankind Pharma part of the Healthcare sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, Mankind Pharma belongs to the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. That sector setting matters because its valuation and return metrics are best read against same-industry peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Mankind_Pharma_Share_Price_on_Univest\"><\/span><strong>Where can I track Mankind Pharma Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Readers can track Mankind Pharma Share Price on Univest for live updates, company ratios, shareholding pattern, 52-week levels and market insights. The platform also helps compare the stock with listed healthcare peers.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mankind Pharma Ltd. Share Price rises to Rs 2,483. marking a 2.19% rise today. Market cap stands at Rs 95,743.85 crore.<\/p>\n","protected":false},"author":29,"featured_media":262104,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-262105","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["262104"],"rank_math_title":["Mankind Pharma Share Price News: Price Rise and Valuation"],"rank_math_description":["Mankind Pharma Share Price rose 2.19% to Rs 2,483. Explore today\u2019s price action, fundamentals, sector context and peer comparison."],"rank_math_focus_keyword":["Mankind Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Mankind_Pharma_Ltd_MANKIND_Mankind_Pharma_Share_Price_Rises_219_Today_to_Rs_2483_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/262105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=262105"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/262105\/revisions"}],"predecessor-version":[{"id":262106,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/262105\/revisions\/262106"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/262104"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=262105"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=262105"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=262105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}